| Charles S Davis, MD | |
|
165 Legrande Ave, Charlotte Court House, VA 23923-3747 | |
| (434) 542-5560 | |
| (434) 542-5745 |
| Full Name | Charles S Davis |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 165 Legrande Ave, Charlotte Court House, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558349886 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 0101025148 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Charles S Davis, MD Highway 15 South, New Canton, VA 23123 Ph: (434) 581-3271 | Charles S Davis, MD 165 Legrande Ave, Charlotte Court House, VA 23923-3747 Ph: (434) 542-5560 |
News Archive
AVEO Pharmaceuticals, Inc. today announced the initiation of patient enrollment in an open-label, multicenter, randomized Phase 2 clinical trial, called BATON-CRC, evaluating tivozanib in combination with modified FOLFOX6 (mFOLFOX6) compared to bevacizumab in combination with mFOLFOX6 as first-line therapy in patients with advanced metastatic colorectal cancer.
Pico-Tesla, The Magneceutical Company, has received the International Organization for Standardization 13485:2003 certificate for the "design, development, production, manufacture and distribution of resonator systems that generate a low-level electromagnetic field for the therapeutic treatment of disease."
In a study published online in advance of print in Stem Cells, Tufts researchers report that the STAT3 gene regulates cancer stem cells in brain cancer. Cancer stem cells have many characteristics of stem cells and are thought to be the cells that drive tumor formation. The researchers report that STAT3 could become a target for cancer therapy, specifically in Glioblastoma multiforme (GBM), a type of malignant and aggressive brain tumor.
"The race to have the first baby is something all hospitals share enthusiasm for, especially in large cities like Chicago, and, unfortunately, not all hospitals play fair," said Karen Deighan, MD, OB/GYN, director of OB/GYN at Gottlieb Memorial Hospital, part of Loyola University Health System.
According to a study published in the July 15 issue of the Journal of Clinical Oncology, genes expressed in benign tissue adjacent to prostate cancer tissue are much more similar to those expressed in prostate cancer tissue than previously thought.
› Verified 8 days ago